Neurocrine Biosciences Stock Predictions

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

NBIX
Neurocrine Biosciences

Last Price:

$100.27

Seasonality Move:

9.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Mode Mobile Could be Next in Line"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Neurocrine Biosciences Stock Forecast

Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 28.9% based on the past 28 years of stock performance.
Neurocrine Biosciences has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Is Neurocrine Biosciences Stock Undervalued?

The current Neurocrine Biosciences [NBIX] share price is $100.10. The Score for NBIX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
NBIX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Neurocrine Biosciences Stock Go Up Next Year?

Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 28.9% based on the past 28 years of stock performance.

Neurocrine Biosciences Stock Rating

Sell

Neurocrine Biosciences (NBIX) is a Sell

Is Neurocrine Biosciences overpriced?

Neurocrine Biosciences has risen higher in 16 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Neurocrine Biosciences Stock Price History

Is NBIX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

neurocrine.com

52-Week Data

52-Week High:

157.98

52-Week Low:

84.23

Prediction Charts

Market Cap:

10B

Price in USD:

100.10

Volume:

3.2M

Beta:

0.78

Technical Analysis

SMA50:

113.00

SMA100:

124.27

SMA200:

127.56

52-Wk Change:

-24.73%

Stock Predictions

Is Neurocrine Biosciences stock public?

Yes, Neurocrine Biosciences is a publicly traded company.
What is the Neurocrine Biosciences stock quote today?

The Neurocrine Biosciences stock price is 100.10 USD today.
How to buy Neurocrine Biosciences stock online?

You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Mar-28	113.36	113.16	114.43	112.15
Mar-31	111.55	110.60	112.60	109.00
Apr-1	110.59	107.00	110.89	106.49
Apr-2	105.94	108.31	108.43	105.78
Apr-3	105.32	102.88	107.53	102.55
Apr-4	99.40	95.65	100.52	93.59
Apr-7	92.90	93.25	96.44	90.33
Apr-8	94.54	87.54	96.00	86.57
Apr-9	85.96	95.28	95.56	84.23
Apr-10	93.17	90.72	94.25	87.70
Apr-11	90.45	90.87	91.28	88.35
Apr-14	94.39	94.89	95.56	92.31
Apr-15	96.88	96.16	98.52	94.30
Apr-16	97.30	100.10	100.66	97.30

Neurocrine Biosciences Earnings

Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Neurocrine Biosciences Forecast Revenue Growth

Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.32 per share, a decrease this year of $0.48 per share, and an increase next year of $2.43 per share.

* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.